{"id":"liquitears","safety":{"commonSideEffects":[{"rate":null,"effect":"Eye irritation"},{"rate":null,"effect":"Blurred vision (transient)"},{"rate":null,"effect":"Allergic reaction to preservatives"}]},"_chembl":null,"_dailymed":{"setId":"79ebe079-e006-4157-9efb-9aadae21e00d","title":"MAJOR LIQUITEARS (POLYVINYL ALCOHOL) SOLUTION/ DROPS [A-S MEDICATION SOLUTIONS]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"LiquiTears works by providing topical lubrication to the cornea and conjunctiva, mimicking natural tear film composition. It helps restore moisture to dry eyes and protects the ocular surface from further irritation and damage. The formulation typically contains demulcents and preservatives designed to provide sustained comfort and symptom relief.","oneSentence":"LiquiTears is an artificial tear solution that lubricates and protects the ocular surface to relieve dry eye symptoms.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:43:23.455Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye syndrome / Keratoconjunctivitis sicca"}]},"trialDetails":[{"nctId":"NCT01977781","phase":"PHASE1","title":"Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease","status":"COMPLETED","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2013-12","conditions":"Ocular GVHD","enrollment":40},{"nctId":"NCT00825721","phase":"PHASE2","title":"Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract","status":"UNKNOWN","sponsor":"Chakshu Research, Inc.","startDate":"2007-11","conditions":"Nuclear Cataract","enrollment":81}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"LiquiTears","genericName":"LiquiTears","companyName":"Chakshu Research, Inc.","companyId":"chakshu-research-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"LiquiTears is an artificial tear solution that lubricates and protects the ocular surface to relieve dry eye symptoms. Used for Dry eye syndrome / Keratoconjunctivitis sicca.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}